Cell-permeable peptide inhibitors of the JNK signal transduction pathway

Details for Australian Patent Application No. 2003274820 (hide)

Owner Xigen SA

Inventors Bonny, Christophe

Agent Cullen & Co

Pub. Number AU-B-2003274820

PCT Number PCT/IB03/03094

PCT Pub. Number WO2003/103698

Priority 10/165,250 07.06.02 US

Filing date 9 June 2003

Wipo publication date 22 December 2003

Acceptance publication date 8 January 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 27/16 (2006.01) Drugs for disorders of the senses

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

12 February 2004 Complete Application Filed

  Priority application(s): 10/165,250 07.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-B-2003274820

12 October 2006 Assignment before Grant

  Universtiry of Lausanne The application has been assigned to Xigen SA

8 January 2009 Application Accepted

  Published as AU-B-2003274820

7 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003274821-A GLANS-STRIPPER AND A DOIT-YOURSELF KIT TO MAKE A GLANS-STRIPPER

2003274819-CD44 SPLICE VARIANT IN DIAGNOSIS AND THERAPY OF INTESTINAL CANCER